Tonix Pharmaceuticals Stock Forum

$Tonix Pharmaceuticals(TNXP.US)$
Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
Tonix Pharmaceuticals (NASDAQ:TNXP) has secured up to $34 million in funding from the U.S. Department of Defense to develop broad-spectrum antiviral agents. The five-year deal with the Defense Threat Reduction Agency (DTRA) aims to improve the medical readiness of military personnel in biological thr...

$Tonix Pharmaceuticals(TNXP.US)$
Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025
Tonix Pharmaceuticals (NASDAQ:TNXP)is preparing to file a New Drug Application (NDA) for Tonmya, its fibromyalgia management drug, in the second half of 2024. The company anticipates FDA approval and commercial launch in the second half of 2025. Tonmya, a non-opioid sublingual tablet, has shown significant improvements in fibromyalgi...

$Tonix Pharmaceuticals(TNXP.US)$
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

$Tonix Pharmaceuticals(TNXP.US)$ If their drug really profitable,a giant whale will aquire them like LLY aquire MORF.

$Tonix Pharmaceuticals(TNXP.US)$ This drug actually haven fully approve by FDA but the big guy always make the news for investor to go in.Now they say that need to submit again by mid 2025 for production.I personally think there will be split share again.Maybe another 2 times.

$Tonix Pharmaceuticals(TNXP.US)$ hi all why suddenly there is no premarket data for today....any news guys....mind share?

$Tonix Pharmaceuticals(TNXP.US)$
lmaooo the XL buys say a lot 💀

$Tonix Pharmaceuticals(TNXP.US)$
Tonix Pharmaceuticals Announces Proposed Public Offering
Tonix Pharmaceuticals announced a proposed public offering of its common stock or pre-funded warrants. The proceeds will be used for working capital, general corporate purposes, including a new drug application for their product candidate Tonmya™, targeting fibromyalgia, and to address existing debt. Dawson James Securities is the sole placement agent. The offering is subject to market conditions and th...